NorthWest Biotherapeutics Inc (NWBO)

[dmb2]

Bacchus1, based on your experience can you reply to a couple of questions?

1) Given the resources big pharma companies have do you see them having an advantage in the publication of important study results since they can provide the supporting studies and reply to such requests rather quickly,...?

2) Have you ever seen a company agree to a delay to publication because the journal offered a more prominent position in the journal, like the first or highlighted article?

3) When you envision the complexities of this trial (endpt and control changes, new regs to interpret, important results for the field) do you see this publication as a more challenging one to manage through the publication process?

Thanks in advance for any perspectives.

GLTA